These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Notch signal pathway and chronic lymphocytic leukemia]. Zhang JY; Xu ZS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1472-5. PubMed ID: 25338610 [TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828 [TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement. Maffei R; Fiorcari S; Martinelli S; Guarnotta C; Benatti S; Belmonte B; Potenza L; Luppi M; Marasca R Hematol Oncol; 2018 Feb; 36(1):372-375. PubMed ID: 28580615 [No Abstract] [Full Text] [Related]
11. NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. Baldoni S; Sportoletti P; Del Papa B; Aureli P; Dorillo E; Rosati E; Ciurnelli R; Marconi P; Falzetti F; Di Ianni M Int J Hematol; 2013 Aug; 98(2):153-7. PubMed ID: 23690290 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653 [TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia. Shukla V; Shukla A; Joshi SS; Lu R Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Fülöp Z; Csernus B; Tímár B; Szepesi A; Matolcsy A Leukemia; 2003 Feb; 17(2):411-5. PubMed ID: 12592341 [TBL] [Abstract][Full Text] [Related]
16. The dual role of HLXB9 in leukemia. Ferguson S; Gautrey HE; Strathdee G Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786 [TBL] [Abstract][Full Text] [Related]
17. From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia. Thurgood LA; Chataway TK; Lower KM; Kuss BJ J Proteomics; 2017 Feb; 155():73-84. PubMed ID: 28069558 [TBL] [Abstract][Full Text] [Related]
18. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947 [TBL] [Abstract][Full Text] [Related]